I became involved with Solving Kids' Cancer (SKC) after becoming familiar with the horrors of neuroblastoma (an almost exclusively pediatric cancer which affects the sympathetic nervous system). After learning about Penelope London's experience, I became committed to improving therapies for this disease, which hasn't seen life expectancy improvements in over 30 years. SKC was founded by Penelope's Dad, John, and Scott Kennedy, another father who also lost his beautiful son Hazen to the disease. After learning about the fledgling organization, I wanted to become involved. I worked part-time for SKC for over a year, helping Scott, John and Pat with their first strategic plan. I've had the honor of getting to know these fine leaders, their commitment to improving life expectancy and quality for these young people, and their urgency to accelerate the therapeutic discovery process. SKC's model is unique in it's approach to assisting innovative researchers in fast-tracking therapies to "market" (clinical trial). Charitable donations are spent exclusively (100%) toward research development, with none going to support the (small) overhead (the Board has committed to underwriting this expense). I have experience working with several non-profits, both as a volunteer and board member. SKC is among the best, with what I feel is the most noble of goals.
Over 1.8 million nonprofits and charities for donors, volunteers and funders
595 Pageviews Read Stories
- EIN 20-8735688
- info@solvingkidscancer.org
- (212) 588-6624
- 1 East 53rd Street 5th Floor New York NY 10022 USA
- www.solvingkidscancer.org
- Facebook page
- SolveKidsCancer
- Add to Favorites
Promote This Nonprofit
Nonprofit Overview
Causes: Cancer, Cancer Research, Health, Health Care, Pediatrics Research
Mission: Solving Kids' Cancer (SKC) finds, funds, and manages clinical research trials to facilitate the development of more effective and less toxic treatments for the deadliest childhood cancers. 100 % of public donations are used for program and research support grants. Operating expenses are provided by SKC's dedicated board of directors.
Programs: SkC actively funds and manages innovative clinical research programs, focusing on aggressive childhood cancers with low survival rates. The clinical trials that SKC funds are designed to accelerate new, next-generation treatments for children alive today, including immunotherapy, cancer vaccines, and new drugs, all with the goal of identifying more effective and less toxic curative paths for the future.